Media ReleasesBARD1 Life Sciences

View All BARD1 Life Sciences News

BARD1 Life Sciences - Terms of issue of Options

Rights and liabilities attaching to the Options

Unless otherwise defined, capitalised terms used below have the meaning given to those terms in the Appendix 3B announced to the market on 23 July 2021.

The Options to be issued to participants in the SPP and Placement under the prospectus will be issued on the following terms and conditions:

(a) Entitlement

Each Option entitles the holder to acquire by way of issue one Share on exercise of the Option.

(b) Exercise Prices

Subject to paragraph (i) below, the Options each Option will have an exercise price of $2.32 (Exercise Price).

For more information, download the attached PDF.

Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.